-
MODEL-BASED COST-UTILITY ANALYSIS OF RECENTLY APPROVED THERAPIES USING RECONSTRUCTED RANDOMIZED CONTROLLED TRIAL OUTCOMES
Feb 25, 2026, 14:40 PM -
MANAGEMENT BASED ON THE INSTITUTIONALIZATION OF HEALTH TECHNOLOGY ASSESSMENT (HTA): THE CASE OF THE ETONOGESTREL SUBDERMAL IMPLANT IN A BRAZILIAN PRIVATE HEALTH INSURANCE
Feb 25, 2026, 14:40 PM -
COST OF HYPERTENSION MANAGEMENT AMONG PEOPLE LIVING WITH HYPERTENSION IN SELECTED PUBLIC HOSPITALS IN ILORIN, NIGERIA
Feb 25, 2026, 14:40 PM -
INTEGRATING PATIENT- AND OBSERVER-REPORTED OUTCOMES INTO VALUE ASSESSMENT FOR PEDIATRIC NEUROBLASTOMA
Feb 25, 2026, 14:40 PM -
PREFERENCES FOR LONG-ACTING PREP ADMINISTRATION AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES
Feb 25, 2026, 14:40 PM -
PREDICTORS OF GLP-1 RECEPTOR AGONIST USE AMONG U.S. ADULTS WITH COMORBID DEPRESSION AND TYPE 2 DIABETES MELLITUS
Feb 25, 2026, 14:40 PM -
CONTENT VALIDITY OF THE EQ-HWB-9 IN PATIENTS WITH ADVANCED ILLNESSES: A COGNITIVE DEBRIEFING STUDY
Feb 25, 2026, 14:40 PM -
HYPERTENSION CONTROL IN TREATED U.S. CANCER SURVIVORS UNDER THE 2017 ACC/AHA GUIDELINE: AN ANALYSIS OF NHANES 2011-2023
Feb 25, 2026, 14:40 PM -
REPORTING AND INTERPRETATION OF COGNITIVE DEBRIEFING RESULTS IN PATIENT REPORTED OUTCOME MEASURE VALIDATION: ARE THERE STANDARDS?
Feb 25, 2026, 14:40 PM -
REDESIGNING MUSCULOSKELETAL REFERRAL PATHWAYS IN EUROPE: SYSTEM-LEVEL EFFECTS OF A DIGITAL-SEROLOGY TRIAGE MODEL
Feb 25, 2026, 14:40 PM -
EQ-5D BASED UTILITY VALUES BY CLINICAL RESPONSE AND SYMPTOM SEVERITY IN JAPANESE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: POST-HOC ANALYSIS OF JAPANESE BREXPIPRAZOLE CLINICAL TRIALS
Feb 25, 2026, 14:40 PM -
COST-UTILITY OF THERAPY WITH 177LU-PSMA: SYSTEMATIC REVIEW OF THE LITERATURE
Feb 25, 2026, 14:40 PM -
RISK OF INFECTIOUS DISEASES AMONG OLDER US ADULTS WITH ALZHEIMER’S DISEASE COMPARED WITH THOSE WITHOUT IN NURSING HOME AND COMMUNITY SETTINGS: A CLAIMS-BASED COHORT STUDY
Feb 25, 2026, 14:40 PM -
EVALUATING CLINICAL OUTCOME ASSESSMENTS IN LOW-RISK MYELODYSPLASTIC SYNDROMES THROUGH DEVELOPMENT OF A COMPREHENSIVE CONCEPTUAL MODEL BASED ON TARGETED LITERATURE REVIEWS AND CLINICIAN INTERVIEWS
Feb 25, 2026, 14:40 PM -
COMPARING LLM-BASED TO EXPERT-CURATED EXTRACTION FOR BIOMARKER ATTRIBUTES IN LUNG AND BREAST CANCER
Feb 25, 2026, 14:40 PM -
BUDGET IMPACT ANALYSIS OF ASCIMINIB FOR THIRD-LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA : A FIVE-YEAR PAYER PERSPECTIVE
Feb 25, 2026, 14:40 PM -
DIRECT ORAL ANTICOAGULANTS VERSUS WARFARIN AFTER ISCHEMIC STROKE IN PATIETS WITH ATRIAL FIBRILLATION: A POPULATION-BASED STUDY FROM BRAZIL
Feb 25, 2026, 14:40 PM -
BUDGET IMPACT ANALYSIS OF DONISLECEL FOR ELIGIBLE ADULTS WITH TYPE I DIABETES IN THE UNITED STATES: AN ANALYSIS FROM A PAYER PERSPECTIVE
Feb 25, 2026, 14:40 PM -
COST-EFFECTIVENESS OF AN AUTOMATED DELIVERY ROBOT PROGRAM TO REDUCE NURSING TRANSPORT BURDEN IN AN INTENSIVE CARE UNIT: A HOSPITAL-PROVIDER PERSPECTIVE
Feb 25, 2026, 14:40 PM -
ASSOCIATION BETWEEN GLP-1 RECEPTOR AGONIST INITIATION AND ALCOHOL USE DISORDER AND ALCOHOL-RELATED MEDICAL CONDITIONS IN A U.S. ADMINISTRATIVE CLAIMS DATABASE
Feb 25, 2026, 14:40 PM
